The Innovative Medicines Initiative is looking to strengthen the role and voice of patients in its activities

21/06/2019

The Innovative Medicines Institute (IMI) has always involved patients in its projects and activities, but it now plans to further strengthen the role and voice of patients in its activities at strategic and operational levels, by creating a pool of patient experts. Patients who are part of the pool would be invited on anad hocbasis to:

  • provide input on IMI’s scientific strategy (annual priorities, topic development etc.), for example by taking part in early consultations and workshops, Strategic Governing Group (SGG) meetings, etc.

  • participate in panels to review project proposals

  • participate in reviews of ongoing and closed projects

  • review the content of documents prepared for patients and the general public

  • participate in IMI events.

Benefits of becoming a member of the pool include the opportunity to:

  • influence IMI’s activities on both strategic and operational levels

  • work alongside experts from other sectors (academia, industry, regulatory, etc.)

  • raise the profile of patients as equal partners in research in the IMI community and beyond

  • learn first-hand about the latest research developments in your disease area.

Patients (and family members and carers) who wish to be part of the pool should submit an Expression of Interest via this form: https://cloud.imi.europa.eu/web/pool-of-patient-platform/pool-of-patients

The deadline for submitting expressions of interest is 16 July 2019 at 17:00 CEST (Central European Summer Time / Brussels time).

Find out more and apply to join the pool of patient experts, here: https://www.imi.europa.eu/get-involved/patients/imi-pool-patient-experts